An early study reported that patients with DM could develop lymphopenia, characterized by low peripheral CD4+ and CD8+ T‐cell and B‐cell absolute counts before initial treatment and a significant increase in lymphocyte counts after treatment.22 The gene discussed is CD8A; the disease is dermatomyositis.